Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 21, 2014; 20(31): 10916-10920
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10916
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10916
Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease
Bülent Yılmaz, Seyfettin Köklü, Osman Yüksel, Serap Arslan, Department of Gastroenterology, Faculty of Medicine, Hacettepe University, Sihhiye, 06100 Ankara, Turkey
Author contributions: Yılmaz B designed the study, collected the data, and drafted the manuscript; Köklü S and Yüksel O collected and analyzed the data; Arslan S designed the study and reviewed the manuscript.
Correspondence to: Bülent Yılmaz, MD, Department of Gastroenterology, Faculty of Medicine, Hacettepe University, Sihhiye, Beytepe Mah., 06100 Ankara, Turkey. bulent.yilmaz@hacettepe.edu.tr
Telephone: +90-505-2993076 Fax: +90-312-3052302
Received: December 26, 2013
Revised: April 2, 2014
Accepted: May 23, 2014
Published online: August 21, 2014
Processing time: 237 Days and 18.5 Hours
Revised: April 2, 2014
Accepted: May 23, 2014
Published online: August 21, 2014
Processing time: 237 Days and 18.5 Hours
Core Tip
Core tip: Endoscopy has been the gold standard for diagnosing and following patients with inflammatory bowel disease (IBD). However, it is still an expensive and invasive method. Beta 2 microglobulin levels of intestinal inflammation represent an easy, non-invasive, cheap and objective diagnostic biomarker for active IBD.